Immunosuppression supports implantation of zona pellucida dissected human embryos.
The effect of low dose immunosuppression with methylprednisolone during the first 4 days after oocyte retrieval on potential immune cell invasion of partially zona dissected embryos in utero was investigated in alternate in vitro fertilization patients (n = 32). The incidence of pregnancy was significantly higher in patients receiving methylprednisolone (7 of 18, 39%) than in control patients (1 of 14, 7%). Twenty-eight percent (11 of 39) of the embryos replaced in the corticosteroid treated patients implanted, whereas only 7% (2 of 31) of embryos in control patients had a fetal heart beat. There were no side effects reported in any of the patients receiving corticosteroids. It can be concluded that methylprednisolone supports implantation of embryos with small holes in their zonae. However, the actual mechanisms of corticosteroid support on the interaction between immune cells and micromanipulated embryos are not well understood.
Cohen
J
J
Reproductive Biology Associates, Emory University School of Medicine, Atlanta, Georgia.
Malter
H
H
Elsner
C
C
Kort
H
H
Massey
J
J
Mayer
M P
MP
D002986:Clinical Trials as Topic; D010064:Embryo Implantation; D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D007165:Immunosuppression Therapy; D007248:Infertility, Male / Q000503:physiopathology; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use*; D011247:Pregnancy; D013752:Tetracycline / Q000627:therapeutic use; D015044:Zona Pellucida / Q000502:physiology
D011239:Prednisolone; D013752:Tetracycline